Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.

A new technique for determining what causes stem cells to convert into other cell types could revolutionise our understanding of how genes function.

New sequencing technology is transforming epigenetics research, and could greatly improve understanding of cancer, embryo formation, stem cells and brain function.

A new £50 million investment business has been launched to support the development of University spin-outs and other early-stage technology companies in the Cambridge Cluster.

Instead of harming the economies of developing countries, carbon offsets and taxes on shipping and aviation would have a minimal or even a positive economic impact if implemented wisely, according to a new study.

Cambridge researchers developing new therapies as part of a collaborative programme with industry.

A new battery technology provides double the energy storage at lower cost than the batteries that are used in handheld electronics, electric vehicles, aerospace and defence.

More than £1 billion in funding has been raised by companies with roots in Cambridge research, according to year-end results from Cambridge Enterprise, the University’s commercialisation arm.

A team from the Centre for Smart Infrastructure and Construction has developed a mechanical amplifier which converts ambient vibrations into electricity more effectively, and could be used to power wireless sensors for monitoring the structural health of roads, bridges and tunnels.

Promising new technique for creating stem cells using a routine blood sample.